Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Adaptive Biotechnologies Corporation (ADPT) had Return on Tangible Equity of -43.71% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$52.44M |
|
$-29.85M |
|
$16.98M |
|
$35.46M |
|
$82.05M |
|
$-29.60M |
|
$-0.23M |
|
$-29.83M |
|
$-29.83M |
|
$-29.83M |
|
$-29.83M |
|
$-29.83M |
|
$-29.83M |
|
$-29.60M |
|
$-25.83M |
|
149.19M |
|
149.19M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$256.49M |
|
$44.43M |
|
$254.36M |
|
$510.85M |
|
$87.81M |
|
-- |
|
$232.82M |
|
$320.63M |
|
$190.22M |
|
$68.24M |
|
$190.22M |
|
151.92M |
|
| Cash Flow Statement Financials | |
$-28.48M |
|
$25.57M |
|
$5.45M |
|
$50.82M |
|
$53.36M |
|
$2.54M |
|
$12.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
67.62% |
|
-56.45% |
|
-56.45% |
|
-- |
|
-56.88% |
|
-56.92% |
|
$-29.74M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.96 |
|
1.20 |
|
74.79 |
|
-15.68% |
|
|
Return on Tangible Equity |
-43.71% |
-5.84% |
|
-15.68% |
|
$1.25 |
|
$-0.20 |
|
$-0.19 |
|